{
    "eid": "2-s2.0-85163621686",
    "title": "Evaluation of Anti-S1 IgA Response to Different COVID-19 Vaccination Regimens",
    "cover-date": "2023-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "COVID-19 vaccine",
        "heterologous",
        "homologous",
        "intradermal (ID)",
        "intramuscular (IM)",
        "severe acute respiratory virus 2 (SARS-CoV-2)",
        "spike 1 specific immunoglobulin A (anti-S1 IgA)"
    ],
    "authors": [
        "Teeraporn C. Bureerug",
        "Sitthichai Kanokudom",
        "Nungruthai Suntronwong",
        "Ritthideach Yorsaeng",
        "Suvichada Assawakosri",
        "Thanunrat Thongmee",
        "Yong Poovorawan"
    ],
    "citedby-count": 0,
    "ref-count": 30,
    "ref-list": [
        "COVID-19: A novel coronavirus and a novel challenge for critical care",
        "Comparison of IgA, IgG, and neutralizing antibody responses following immunization with Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm\u2019s COVID-19 vaccines",
        "Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens",
        "Immunogenicity of the BNT162b2 COVID-19 vaccine as a third dose (booster) following two doses of different primary series regimens in Thailand",
        "Comparison of serum total IgA levels in severe and mild COVID 19 patients and control group",
        "IgA: Structure, function, and developability",
        "Glycosylation of human IgA directly inhibits influenza A and other sialic-acid-binding viruses",
        "Relationship of serum immunoglobulin levels to blood pressure and hypertension in an adult population",
        "Mucosal immunization and adjuvants",
        "Role of IgA versus IgG in the control of infuenza viral infection in the murine respiratory tract",
        "Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults",
        "IgA dominates the early neutralizing antibody response to SARS-CoV-2",
        "Elevated serum IgA following vaccination against SARS-CoV-2 in a cohort of high-risk first responders",
        "Human IgG and IgA responses to COVID-19 mRNA vaccines",
        "Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults",
        "Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: A prospective cohort study",
        "Immunogenicity of heterologous prime/boost inactivated and mRNA COVID-19 vaccine",
        "Neutralizing activities against the Omicron variant after a heterologous booster in healthy adults receiving two doses of CoronaVac vaccination",
        "The fourth dose of mRNA COVID-19 vaccine following 12 different three-dose regimens: Safety and immunogenicity to Omicron BA.4/BA.5",
        "Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3 to 4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination",
        "Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients",
        "Immunogenicity and safety of an intradermal BNT162b2 mRNA vaccine booster after two doses of inactivated SARS-COV-2 vaccine in healthy population",
        "Immunogenicity and reactogenicity of mRNA COVID-19 vaccine booster administered by intradermal or intramuscular route in Thai Older adults",
        "Modeling of waning immunity after SARS-COV-2 vaccination and influencing factors",
        "Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong",
        "Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management",
        "Mucosal Vaccines, Sterilizing immunity, and the future of SARS-CoV-2 virulence",
        "Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection",
        "Human immune responses to influenza virus vaccines administered by systemic or mucosal routes",
        "Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60005800",
            "affilname": "Faculty of Medicine, Srinakharinwirot University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005800",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "129881673",
            "affilname": "Royal Society of Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/129881673",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Clinical Virology",
        "Faculty of Medicine, Srinakharinwirot University",
        "Group Aunt Thongkum Foundation",
        "Second Century Fund",
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University",
        "National Research Council of Thailand",
        "Health Systems Research Institute"
    ]
}